LU86343A1 - Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren - Google Patents
Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren Download PDFInfo
- Publication number
- LU86343A1 LU86343A1 LU86343A LU86343A LU86343A1 LU 86343 A1 LU86343 A1 LU 86343A1 LU 86343 A LU86343 A LU 86343A LU 86343 A LU86343 A LU 86343A LU 86343 A1 LU86343 A1 LU 86343A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- solution
- sisomicin
- pharmaceutical compositions
- antioxidant
- compositions according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU85859A HU197514B (en) | 1985-03-07 | 1985-03-07 | Process for production of injection sulution containing acid-additional salts od sysomicin |
HU85985 | 1985-03-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU86343A1 true LU86343A1 (fr) | 1986-06-24 |
Family
ID=10951729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU86343A LU86343A1 (fr) | 1985-03-07 | 1986-03-06 | Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0195114B1 (it) |
JP (1) | JPS61267523A (it) |
CN (1) | CN1010551B (it) |
AU (1) | AU587014B2 (it) |
BE (1) | BE904289A (it) |
CA (1) | CA1267091A (it) |
DD (1) | DD243208A5 (it) |
DE (1) | DE3577657D1 (it) |
DK (1) | DK165669C (it) |
ES (1) | ES8704078A1 (it) |
GB (1) | GB2171907B (it) |
GR (1) | GR851869B (it) |
HU (1) | HU197514B (it) |
IL (1) | IL77958A0 (it) |
IT (1) | IT1203543B (it) |
LU (1) | LU86343A1 (it) |
NL (1) | NL8600480A (it) |
PT (1) | PT82144B (it) |
SE (1) | SE466384B (it) |
SU (1) | SU1440328A3 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115671044A (zh) * | 2022-11-29 | 2023-02-03 | 江苏四环生物制药有限公司 | 一种硫酸奈替米星注射液及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962429A (en) * | 1973-08-01 | 1976-06-08 | Chugai Seiyaku Kabushiki Kaisha | Method for reducing side effects of aminoglycoside antibiotics and composition therefor |
DE2726208A1 (de) * | 1977-06-10 | 1978-12-21 | Bayer Ag | 1-n-formylsisomicin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel |
US4327087A (en) * | 1978-01-16 | 1982-04-27 | Schering Corporation | Stabilized Netilmicin formulations |
US4223022A (en) * | 1978-01-16 | 1980-09-16 | Schering Corporation | Stabilized aminoglycoside antibiotic formulations |
-
1985
- 1985-03-07 HU HU85859A patent/HU197514B/hu not_active IP Right Cessation
- 1985-07-29 GR GR851869A patent/GR851869B/el unknown
- 1985-07-31 DE DE8585109621T patent/DE3577657D1/de not_active Expired - Fee Related
- 1985-07-31 EP EP85109621A patent/EP0195114B1/en not_active Expired - Lifetime
- 1985-09-09 CN CN85106763A patent/CN1010551B/zh not_active Expired
-
1986
- 1986-02-20 AU AU53845/86A patent/AU587014B2/en not_active Ceased
- 1986-02-21 DD DD86287250A patent/DD243208A5/de unknown
- 1986-02-21 IL IL77958A patent/IL77958A0/xx not_active IP Right Cessation
- 1986-02-26 NL NL8600480A patent/NL8600480A/nl not_active Application Discontinuation
- 1986-02-26 BE BE0/216317A patent/BE904289A/fr not_active IP Right Cessation
- 1986-03-04 IT IT67172/86A patent/IT1203543B/it active
- 1986-03-05 PT PT82144A patent/PT82144B/pt unknown
- 1986-03-06 DK DK101786A patent/DK165669C/da not_active IP Right Cessation
- 1986-03-06 CA CA000503435A patent/CA1267091A/en not_active Expired - Lifetime
- 1986-03-06 SE SE8601050A patent/SE466384B/sv not_active IP Right Cessation
- 1986-03-06 ES ES552709A patent/ES8704078A1/es not_active Expired
- 1986-03-06 LU LU86343A patent/LU86343A1/de unknown
- 1986-03-06 JP JP61049489A patent/JPS61267523A/ja active Granted
- 1986-03-07 SU SU864027095A patent/SU1440328A3/ru active
- 1986-03-07 GB GB8605629A patent/GB2171907B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IT1203543B (it) | 1989-02-15 |
EP0195114B1 (en) | 1990-05-16 |
BE904289A (fr) | 1986-06-16 |
EP0195114A2 (en) | 1986-09-24 |
SE466384B (sv) | 1992-02-10 |
EP0195114A3 (en) | 1988-02-03 |
NL8600480A (nl) | 1986-10-01 |
SE8601050D0 (sv) | 1986-03-06 |
HUT40758A (en) | 1987-02-27 |
ES552709A0 (es) | 1987-04-01 |
PT82144A (en) | 1986-04-01 |
DK101786D0 (da) | 1986-03-06 |
DK101786A (da) | 1986-09-08 |
DD243208A5 (de) | 1987-02-25 |
IT8667172A0 (it) | 1986-03-04 |
AU5384586A (en) | 1986-09-11 |
IL77958A0 (en) | 1986-08-31 |
DE3577657D1 (de) | 1990-06-21 |
JPS61267523A (ja) | 1986-11-27 |
PT82144B (pt) | 1988-02-17 |
SU1440328A3 (ru) | 1988-11-23 |
DK165669B (da) | 1993-01-04 |
GB8605629D0 (en) | 1986-04-16 |
JPH0572365B2 (it) | 1993-10-12 |
DK165669C (da) | 1993-06-14 |
SE8601050L (sv) | 1986-09-08 |
AU587014B2 (en) | 1989-08-03 |
CN1010551B (zh) | 1990-11-28 |
GB2171907B (en) | 1989-06-14 |
HU197514B (en) | 1989-04-28 |
CN85106763A (zh) | 1987-02-11 |
GB2171907A (en) | 1986-09-10 |
ES8704078A1 (es) | 1987-04-01 |
GR851869B (it) | 1985-12-02 |
CA1267091A (en) | 1990-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3303860C2 (it) | ||
DE3240177C2 (it) | ||
DE602005002495T2 (de) | Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat | |
EP2766008B1 (de) | Zusammensetzung für die nasale applikation mit verbesserter stabilität | |
EP0166971A1 (de) | Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung | |
CH676549A5 (it) | ||
LU86343A1 (fr) | Stabilisierte injectionszusammensetzungen und ihre herstellungsverfahren | |
DE2606106A1 (de) | Hydroxyamine, verfahren zu deren herstellung und verwendung derselben | |
DE60101979T2 (de) | Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel | |
EP0241804B1 (de) | Konservierte Antacida-Zubereitungen | |
LU86115A1 (de) | Metallkomplexe der bis-indolverbindungen und diese enthaltende arneimittelpraeparate | |
DE102004052877B4 (de) | Stabile wässrige Formulierungen eines Platin-Derivats | |
DE2716535B2 (de) | Verwendung von D-Glucaro-13-lactam | |
DE977478C (de) | Verfahren zur Herstellung injizierbarer Insulinpraeparate mit verzoegerter Wirkung | |
DE2411019C2 (de) | Verwendung von 1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinon oder 1-(2-Oxo-1-pyrrolidin)-4-(1-pyrrolidin)-2-butyn zur Behandlung von Glaucoma | |
DE69728220T2 (de) | Antitumormittel mit silizium und stickstoff enthaltenden verbindungen als hauptbestandteil | |
EP0152860B1 (de) | Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems | |
DE3701461C2 (it) | ||
DE19518917A1 (de) | Stabile, konzentrierte lokalverträgliche Erythromycylamin-Lösungen | |
DE1595951A1 (de) | Verfahren zur Herstellung von Desoxyuridinverbindungen | |
EP1282422A1 (de) | Infusionslösungen des ciprofloxacins mit verbesserter lagerfähigkeit | |
EP0653210A1 (de) | Intravenös verabreichbare wässrige Lösung von Sulfametrol und Trimethoprim | |
EP4245294A1 (de) | Kathetergleitgel mit erhöhter stabilität | |
DE3720654A1 (de) | Verfahren zur verhinderung der verfaerbung waessriger cefmenoxim-praeparate | |
DEF0016953MA (it) |